Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11171916.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cognitive and functional outcomes are of primary interest in the design of efficacy trials in HIV-associated cognitive impairment. In a longitudinal cohort study, weak associations were found between measures of cognitive performance and commonly used measures of daily functioning (mostly self-report measures) in HIV-infected individuals. Modifications of current functional scales or new functional instruments are needed to assess the clinical relevance of cognitive changes in clinical trials of HIV-associated cognitive impairment.
Medical subject headings
- AIDS Dementia Complex
- Clinical Trials as Topic